Globus Medical, Inc. shines with strong Q4 results & Nevro acquisition, boosting its market position. Click here to find out ...

According to Benzinga Pro, Globus Medical's peer group average for short interest as a percentage of float is 4.39%, which ...

Decades of market research shows that the best-performing stocks often have an 80 or higher RS Rating in the early stages of ...

Globus Medical currently trades at $75.69 per share and has shown little upside over the past six months, posting a middling ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

TOKYO, JAPAN- Six months after its CEO resigned amid allegations he purchased illegal drugs, med-tech company Olympus ...

Inspire Medical, developer of a pacemaker-like device for treating sleep apnea is hiring two senior medical directors.

Olympus announced today that it appointed Bob White, former Medtronic EVP, as its new CEO, effective June 1, 2025.